USDN3 Riley Paulsen

USD-N3 Graduate Training Program

Diverse training with unlimited possibilities.

The USD-N3 program provides training in the development of novel nanotechnology-derived tools aimed at both understanding the brain and potentially treating disorders of the brain. Our students receive tuition and stipend support, including an annual stipend of $34,000 for two years during training.

Our unique program emphasizes microtracks - a series of non-science courses that will prepare you for careers in:

  • Biotechnology
  • Scientific writing and editing
  • Government and public policy
  • Education

Apply Today

Support is limited to U.S. citizens and permanent residents. When applying through the Basic Biomedical Sciences graduate programs, check the USD-N3 box on your application. When applying through the Department of Chemistry graduate program, indicate your interest in the state of purpose section.

News in Brief

  • Richard Tankersley

    STEM Professional Development Workshop - Oct. 31

    Richard Tankersley, Ph.D., will present on careers in government agencies and non-academic positions in universities. Tankersley is currently interim vice chancellor for research and economic development and associate dean for research and graduate education at University of North Carolina at Charlotte. He previously served as a program director for the directorate of graduate education at the National Science Foundation. This workshop takes place from 3-5 p.m. in Lee Medical Science Building, room 105.

  • Photo of N3 Cohort in front of Old Main.
    VERMILLION, S.D. – The first cohort of fellows participating in the National Science Foundation sponsored University of South Dakota–Neuroscience, Nanotechnology & Networks Program (USD-N3), are finishing their first semester of coursework this fall.
  • Graduate Student Travel Award Winners

    Congratulations to: Clarissa Staton, biology, who is attending the Society for Neuroscience Conference; Casey Finnicum, basic biomedical sciences, who is attending the American Society of Human Genetics Annual Meeting; and Pasan Fernando, biology, who is attending the IEEE International Conference on Bioinformatics and Biomedicine.